KIA
LLY icon

Kraematon Investment Advisors’s Eli Lilly LLY Stock Holding History

Kraematon Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$995K Hold
829
– – 0.74% 43
2026
Q1 		$762K Buy
829
+1
+0.1% +$1.01K 0.62% 51
2025
Q4 		$890K Buy
828
+28
+4% +$26.8K 0.71% 40
2025
Q3 		$611K Sell
800
-113
-12% -$84.1K 0.52% 54
2025
Q2 		$711K Sell
913
-141
-13% -$110K 0.67% 48
2025
Q1 		$870K Sell
1,054
-97
-8% -$80.7K 0.89% 36
2024
Q4 		$889K Buy
1,151
+1
+0.1% +$828 0.88% 39
2024
Q3 		$1.02M Buy
1,150
+155
+16% +$139K 1% 34
2024
Q2 		$901K Sell
995
-24
-2% -$19.2K 0.92% 37
2024
Q1 		$793K Buy
1,019
+40
+4% +$28.5K 0.8% 42
2023
Q4 		$571K Buy
+979
New +$571K 0.63% 47
2023
Q1 		– Sell
-168
Closed -$61.5K – 171
2022
Q4 		$61.5K Buy
+168
New +$59.6K 0.07% 120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kraematon Investment Advisors's LLY Position: Q2 2026 in Review

Kraematon Investment Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 829 shares worth $995K. The position accounts for 0.74% of the portfolio, ranked #43.

Kraematon Investment Advisors first reported a position in LLY in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.02M in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kraematon Investment Advisors held 829 shares of Eli Lilly worth $995K as of Q2 2026.
  • Kraematon Investment Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.74% of Kraematon Investment Advisors's portfolio in Q2 2026, its #43 holding.
  • Kraematon Investment Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 12 quarters since.
  • Kraematon Investment Advisors's Eli Lilly position peaked at $1.02M in Q3 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kraematon Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.